Swiss National Bank’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $15.1M | Buy |
229,800
+5,600
| +2% | +$356K | 0.01% | 757 |
|
|
2025
Q4 | $14.2M | Buy |
224,200
+4,300
| +2% | +$267K | 0.01% | 799 |
|
|
2025
Q3 | $12.1M | Buy |
219,900
+3,700
| +2% | +$152K | 0.01% | 868 |
|
|
2025
Q2 | $7.14M | Sell |
216,200
-1,000
| -0.5% | -$34.8K | ﹤0.01% | 1093 |
|
|
2025
Q1 | $8.73M | Sell |
217,200
-2,600
| -1% | -$119K | 0.01% | 964 |
|
|
2024
Q4 | $10.3M | Buy |
219,800
+4,300
| +2% | +$223K | 0.01% | 930 |
|
|
2024
Q3 | $11.4M | Buy |
215,500
+20,000
| +10% | +$1.11M | 0.01% | 875 |
|
|
2024
Q2 | $10.6M | Buy |
195,500
+21,300
| +12% | +$1.29M | 0.01% | 877 |
|
|
2024
Q1 | $12.2M | Buy |
174,200
+3,900
| +2% | +$302K | 0.01% | 827 |
|
|
2023
Q4 | $14.2M | Sell |
170,300
-29,500
| -15% | -$1.07M | 0.01% | 729 |
|
|
2023
Q3 | $5.89M | Buy |
199,800
+2,100
| +1% | +$69.9K | ﹤0.01% | 1184 |
|
|
2023
Q2 | $6.45M | Buy |
197,700
+3,700
| +2% | +$137K | ﹤0.01% | 1153 |
|
|
2023
Q1 | $6.83M | Sell |
194,000
-22,000
| -10% | -$897K | ﹤0.01% | 1078 |
|
|
2022
Q4 | $9.9M | Buy |
216,000
+23,000
| +12% | +$990K | 0.01% | 919 |
|
|
2022
Q3 | $9.35M | Buy |
193,000
+5,300
| +3% | +$255K | 0.01% | 914 |
|
|
2022
Q2 | $7.38M | Buy |
187,700
+9,200
| +5% | +$370K | 0.01% | 1080 |
|
|
2022
Q1 | $6.57M | Buy |
178,500
+13,200
| +8% | +$469K | ﹤0.01% | 1275 |
|
|
2021
Q4 | $7.53M | Buy |
165,300
+3,200
| +2% | +$123K | ﹤0.01% | 1190 |
|
|
2021
Q3 | $5.79M | Buy |
162,100
+37,300
| +30% | +$1.1M | ﹤0.01% | 1357 |
|
|
2021
Q2 | $2.47M | Sell |
124,800
-20,700
| -14% | -$486K | ﹤0.01% | 1963 |
|
|
2021
Q1 | $3.38M | Buy |
145,500
+2,000
| +1% | +$42.7K | ﹤0.01% | 1690 |
|
|
2020
Q4 | $2.98M | Buy |
143,500
+7,300
| +5% | +$133K | ﹤0.01% | 1680 |
|
|
2020
Q3 | $2.95M | Buy |
136,200
+24,100
| +21% | +$564K | ﹤0.01% | 1512 |
|
|
2020
Q2 | $2.64M | Buy |
112,100
+14,700
| +15% | +$276K | ﹤0.01% | 1548 |
|
|
2020
Q1 | $1.15M | Buy |
97,400
+2,000
| +2% | +$25.5K | ﹤0.01% | 1746 |
|
|
2019
Q4 | $1.01M | Buy |
95,400
+3,300
| +4% | +$33.9K | ﹤0.01% | 2133 |
|
|
2019
Q3 | $1.05M | Buy |
92,100
+5,500
| +6% | +$69K | ﹤0.01% | 2036 |
|
|
2019
Q2 | $974K | Buy |
86,600
+4,500
| +5% | +$43.4K | ﹤0.01% | 2127 |
|
|
2019
Q1 | $664K | Hold |
82,100
| – | – | ﹤0.01% | 2280 |
|
|
2018
Q4 | $519K | Sell |
82,100
-3,300
| -4% | -$24.2K | ﹤0.01% | 2343 |
|
|
2018
Q3 | $841K | Hold |
85,400
| – | – | ﹤0.01% | 2237 |
|
|
2018
Q2 | $709K | Buy |
85,400
+11,300
| +15% | +$94K | ﹤0.01% | 2339 |
|
|
2018
Q1 | $534K | Buy |
74,100
+8,900
| +14% | +$76.3K | ﹤0.01% | 2355 |
|
|
2017
Q4 | $531K | Hold |
65,200
| – | – | ﹤0.01% | 2392 |
|
|
2017
Q3 | $945K | Buy |
65,200
+7,600
| +13% | +$104K | ﹤0.01% | 2094 |
|
|
2017
Q2 | $697K | Buy |
+57,600
| New | +$800K | ﹤0.01% | 2277 |
|
Other funds holding CYTK
VPM
VCM
ACA
